{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:59:33Z","timestamp":1780984773988,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10067-026-08138-3","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:27:48Z","timestamp":1777483668000},"page":"3311-3326","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction and validation of a glycosylation-related diagnostic model and immune characterization in lupus nephritis"],"prefix":"10.1007","volume":"45","author":[{"given":"Li\u2019nan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2506-0574","authenticated-orcid":false,"given":"Yixian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"1","key":"8138_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-025-00653-y","volume":"11","author":"I Parodis","year":"2025","unstructured":"Parodis I, Rovin BH, Tektonidou MG, Anders HJ, Malvar A, Mok CC et al (2025) Lupus nephritis. Nat Rev Dis Primers 11(1):69. https:\/\/doi.org\/10.1038\/s41572-025-00653-y","journal-title":"Nat Rev Dis Primers"},{"key":"8138_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14242787","author":"C Tang","year":"2024","unstructured":"Tang C, Teymur A, Wu T (2024) Urinary immune complexes reflect renal pathology in Lupus nephritis. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics14242787","journal-title":"Diagnostics (Basel)"},{"issue":"10","key":"8138_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275016","volume":"17","author":"JAR Guimar\u00e3es","year":"2022","unstructured":"Guimar\u00e3es JAR, Furtado SDC, Lucas A, Mori B, Barcellos JFM (2022) Diagnostic test accuracy of novel biomarkers for Lupus nephritis-an overview of systematic reviews. PLoS One 17(10):e0275016. https:\/\/doi.org\/10.1371\/journal.pone.0275016","journal-title":"PLoS One"},{"key":"8138_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1421657","volume":"15","author":"Q Guo","year":"2024","unstructured":"Guo Q, Qiao P, Wang J, Zhao L, Guo Z, Li X et al (2024) Investigating the value of urinary biomarkers in relation to Lupus nephritis histopathology: present insights and future prospects. Front Pharmacol 15:1421657. https:\/\/doi.org\/10.3389\/fphar.2024.1421657","journal-title":"Front Pharmacol"},{"key":"8138_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195759","author":"L Palazzo","year":"2022","unstructured":"Palazzo L, Lindblom J, Mohan C, Parodis I (2022) Current insights on biomarkers in Lupus nephritis: a systematic review of the literature. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11195759","journal-title":"J Clin Med"},{"key":"8138_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000569","author":"Z Mao","year":"2021","unstructured":"Mao Z, Tan Y, Yu F, Zhao M (2021) Discovery of NEU1 as a candidatedone. renal biomarker for proliferative Lupus nephritis chronicity. Lupus Sci Med. https:\/\/doi.org\/10.1136\/lupus-2021-000569","journal-title":"Lupus Sci Med"},{"key":"8138_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02754","volume":"9","author":"MS Pereira","year":"2018","unstructured":"Pereira MS, Alves I, Vicente M, Campar A, Silva MC, Padr\u00e3o NA et al (2018) Glycans as key checkpoints of T cell activity and function. Front Immunol 9:2754. https:\/\/doi.org\/10.3389\/fimmu.2018.02754","journal-title":"Front Immunol"},{"issue":"1","key":"8138_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","volume":"9","author":"M He","year":"2024","unstructured":"He M, Zhou X, Wang X (2024) Glycosylation: mechanisms, biological functions and clinical implications. Signal Transduct Target Ther 9(1):194. https:\/\/doi.org\/10.1038\/s41392-024-01886-1","journal-title":"Signal Transduct Target Ther"},{"key":"8138_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001413","author":"Y Wu","year":"2025","unstructured":"Wu Y, Wang M, Hu C, Zhang S, Zhao J, Wang Q et al (2025) IgG glycosylation profiling of Systemic Lupus Erythematosus using lectin microarray. Lupus Sci Med. https:\/\/doi.org\/10.1136\/lupus-2024-001413","journal-title":"Lupus Sci Med"},{"key":"8138_CR10","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147789","author":"R Bhargava","year":"2021","unstructured":"Bhargava R, Lehoux S, Maeda K, Tsokos MG, Krishfield S, Ellezian L et al (2021) Aberrantly glycosylated IgG elicits pathogenic signaling in podocytes and signifies Lupus nephritis. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.147789","journal-title":"JCI Insight"},{"issue":"3","key":"8138_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbaf017","volume":"8","author":"Y Ling","year":"2025","unstructured":"Ling Y, Cai F, Su T, Zhong Y, Li L, Meng B et al (2025) Glycosylation in kidney diseases. Precision Clinical Medicine 8(3):pbaf017. https:\/\/doi.org\/10.1093\/pcmedi\/pbaf017","journal-title":"Precision Clinical Medicine"},{"issue":"10","key":"8138_CR12","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/s41423-023-01074-1","volume":"20","author":"SS Pinho","year":"2023","unstructured":"Pinho SS, Alves I, Gaifem J, Rabinovich GA (2023) Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection. Cell Mol Immunol 20(10):1101\u20131113. https:\/\/doi.org\/10.1038\/s41423-023-01074-1","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"8138_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41584-023-00960-2","volume":"19","author":"R Phillips","year":"2023","unstructured":"Phillips R (2023) Mannosylation is a cause and target in Lupus nephritis. Nat Rev Rheumatol 19(5):258. https:\/\/doi.org\/10.1038\/s41584-023-00960-2","journal-title":"Nat Rev Rheumatol"},{"key":"8138_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00877","volume":"8","author":"G Dekkers","year":"2017","unstructured":"Dekkers G, Treffers L, Plomp R, Bentlage AEH, de Boer M, Koeleman CAM et al (2017) Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities. Front Immunol 8:877. https:\/\/doi.org\/10.3389\/fimmu.2017.00877","journal-title":"Front Immunol"},{"key":"8138_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169281","author":"M Radanova","year":"2022","unstructured":"Radanova M, Vasilev V, Mihaylova G, Kosturkova M, Kishore U, Roumenina L (2022) Autoantibodies against complement classical pathway components C1q, C1r, C1s and C1-Inh in patients with Lupus nephritis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23169281","journal-title":"Int J Mol Sci"},{"issue":"3","key":"8138_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/jb\/mvy098","volume":"165","author":"K Nakayama","year":"2019","unstructured":"Nakayama K, Wakamatsu K, Fujii H, Shinzaki S, Takamatsu S, Kitazume S et al (2019) Core fucose is essential glycosylation for CD14-dependent Toll-like receptor 4 and Toll-like receptor 2 signalling in macrophages. J Biochem 165(3):227\u2013237. https:\/\/doi.org\/10.1093\/jb\/mvy098","journal-title":"J Biochem"},{"key":"8138_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1600206","volume":"16","author":"H Gao","year":"2025","unstructured":"Gao H, Zhang Z, Deng J, Song Y (2025) Cathepsin S: molecular mechanisms in inflammatory and immunological processes. Front Immunol 16:1600206. https:\/\/doi.org\/10.3389\/fimmu.2025.1600206","journal-title":"Front Immunol"},{"issue":"2","key":"8138_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/annrheumdis-2013-203717","volume":"74","author":"KV Rupanagudi","year":"2015","unstructured":"Rupanagudi KV, Kulkarni OP, Lichtnekert J, Darisipudi MN, Mulay SR, Schott B et al (2015) Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming. Ann Rheum Dis 74(2):452\u2013463. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203717","journal-title":"Ann Rheum Dis"},{"key":"8138_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/309718","volume":"2014","author":"M Novinec","year":"2014","unstructured":"Novinec M, Lenar\u010di\u010d B, Turk B (2014) Cysteine cathepsin activity regulation by glycosaminoglycans. BioMed Res Int 2014:309718. https:\/\/doi.org\/10.1155\/2014\/309718","journal-title":"BioMed Res Int"},{"key":"8138_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914526","author":"Y Renaudineau","year":"2023","unstructured":"Renaudineau Y, Brooks W, Belliere J (2023) Lupus nephritis risk factors and biomarkers: an update. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241914526","journal-title":"Int J Mol Sci"},{"key":"8138_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1257906","volume":"14","author":"X Lu","year":"2023","unstructured":"Lu X, Wang L, Wang M, Li Y, Zhao Q, Shi Y et al (2023) Association between immunoglobulin G N-glycosylation and lupus nephritis in female patients with systemic lupus erythematosus: a case-control study. Front Immunol 14:1257906. https:\/\/doi.org\/10.3389\/fimmu.2023.1257906","journal-title":"Front Immunol"},{"issue":"4","key":"8138_CR22","first-page":"767","volume":"38","author":"X Li","year":"2020","unstructured":"Li X, Xu J, Li M, Zeng X, Wang J, Hu C (2020) Aberrant glycosylation in autoimmune disease. Clin Exp Rheumatol 38(4):767\u2013775","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"8138_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-024-03311-y","volume":"26","author":"S Wei","year":"2024","unstructured":"Wei S, Shen H, Zhang Y, Liu C, Li S, Yao J et al (2024) Integrative analysis of single-cell and bulk transcriptome data reveal the significant role of macrophages in lupus nephritis. Arthritis Res Ther 26(1):84. https:\/\/doi.org\/10.1186\/s13075-024-03311-y","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"8138_CR24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.kint.2022.06.028","volume":"102","author":"SW Jackson","year":"2022","unstructured":"Jackson SW, Alpers CE (2022) Lupus nephritis transcriptomics across space and time. Kidney Int 102(4):694\u2013696. https:\/\/doi.org\/10.1016\/j.kint.2022.06.028","journal-title":"Kidney Int"},{"key":"8138_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105785","volume":"117","author":"S Shang","year":"2025","unstructured":"Shang S, Xia J, He G, Zheng Y, Zhang J, Lu H et al (2025) Advances in precision medicine for lupus nephritis: biomarker- and AI-driven diagnosis and treatment response prediction and targeted therapies. EBioMedicine 117:105785. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105785","journal-title":"EBioMedicine"},{"key":"8138_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020476","author":"E Senjor","year":"2023","unstructured":"Senjor E, Kos J, Nanut MP (2023) Cysteine cathepsins as therapeutic targets in immune regulation and immune disorders. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11020476","journal-title":"Biomedicines"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08138-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08138-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08138-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:25:40Z","timestamp":1780982740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08138-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["8138"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08138-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable. This study does not include any human or animal testers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trial registration number"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Grant number"}}]}}